ACLARION, INC. Fair Value Adjustment of Warrants
ACLARION, INC. (ACON) reported Fair Value Adjustment of Warrants of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-06
- ACLARION, INC. fair value adjustment of warrants for the quarter ending 2026-06-30 was $0.00.
- ACLARION, INC. fair value adjustment of warrants for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ACLARION, INC. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- ACLARION, INC. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00.
- ACLARION, INC. fair value adjustment of warrants for fiscal 2025 was $48.09K.
- ACLARION, INC. fair value adjustment of warrants for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ACLARION, INC. fair value adjustment of warrants for fiscal 2023 was $1.06M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $48.09K 10-K · filed 2026-03-18 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $48.09K 10-Q · filed 2025-11-12 | $48.09K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $48.09K 10-Q · filed 2026-08-06 | $48.09K derived: sum of 3 quarters · filed 2026-08-06 | $48.09K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $48.09K 10-Q · filed 2026-05-13 | $48.09K derived: sum of 2 quarters · filed 2026-05-13 | $48.09K derived: sum of 3 quarters · filed 2026-05-13 | $48.09K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $0.00 derived: sum of 3 quarters · filed 2026-03-18 | $0.00 10-K · filed 2026-03-18 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $160.01K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $160.01K derived: sum of 3 quarters · filed 2025-08-14 | $313.82K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $160.01K derived: sum of 2 quarters · filed 2025-05-15 | $313.82K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $160.01K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $313.82K derived: sum of 2 quarters · filed 2024-03-28 | $1.06M 10-K · filed 2024-03-28 | |
| 2023-09-30 | $153.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $896.80K 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $742.99K 10-Q · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |